KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to -$50.0 million.

  • Novartis Ag's Treasury Shares rose 566.04% to -$50.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$50.0 million, marking a year-over-year increase of 566.04%. This contributed to the annual value of -$50.0 million for FY2025, which is 566.04% up from last year.
  • As of Q4 2025, Novartis Ag's Treasury Shares stood at -$50.0 million, which was up 566.04% from -$44.0 million recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Treasury Shares ranged from a high of $92.0 million in Q4 2022 and a low of -$70.0 million during Q3 2022
  • Its 5-year average for Treasury Shares is -$29.1 million, with a median of -$42.0 million in 2024.
  • As far as peak fluctuations go, Novartis Ag's Treasury Shares surged by 9166.67% in 2022, and later plummeted by 22926.83% in 2024.
  • Novartis Ag's Treasury Shares (Quarter) stood at $48.0 million in 2021, then skyrocketed by 91.67% to $92.0 million in 2022, then crashed by 55.43% to $41.0 million in 2023, then tumbled by 229.27% to -$53.0 million in 2024, then increased by 5.66% to -$50.0 million in 2025.
  • Its Treasury Shares was -$50.0 million in Q4 2025, compared to -$44.0 million in Q3 2025 and -$33.0 million in Q2 2025.